Gartner: Midsize Enterprises Must Prioritize to Achieve Effective Vulnerability Management
Are you a midsize enterprise struggling to manage vulnerabilities? Consider a risk-based approach to prioritization, as recommended by Gartner.
“By 2025, 70% of MSEs that take a traditional, volume approach to vulnerability management will have been breached through a known vulnerability.”– Midsize Enterprises Must Prioritize to Achieve Effective Vulnerability Management, Gartner, 2019
Midsize enterprises (MSEs) are expected to protect an expanding attack surface – without additional resources. As the number of vulnerabilities continues to pile up, it’s essential to bring prioritization into your security program strategy to ensure the vulnerabilities with the highest likelihood of exploitation are addressed first.
If you’re looking to better understand this risk-based approach, and the key things to consider as you start this effort, read Gartner’s Midsize Enterprises Must Prioritize to Achieve Effective Vulnerability Management. In this report, you’ll:
- Learn the limitations of prioritizing remediation efforts based on CVSS alone
- Find out which vendors have prioritization features available
- See how risk-based vulnerability management helps you focus on the threats most likely to be exploited
Source: Gartner, Midsize Enterprises Must Prioritize to Achieve Effective Vulnerability Management, 26 Nov 2019, Patrick Long, Mitchell Schneider. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and is used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.